Application of Nano-biotechnology for Improvement in Therapeutic Approaches for the Treatment of Diabetes
Explore this paper's citation graph
Summary
The way in which nanotechnology could be used to effectively treat, and possibly cure, diabetes is explored.
- Type
- article
- Published
- 2018-01-01
- Cited by
- 5
- References
- 106
- Access
- Open access
- OpenAlex
- https://openalex.org/W2805163669
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:55315413
Keywords
Diabetes mellitus, Type 2 diabetes, Nanosensor, Medicine, Drug delivery
References
- Imaging dynamic insulin release using a fluorescent zinc indicator for monitoring induced exocytotic release (ZIMIR)
- Nanomaterial-mediated Biosensors for Monitoring Glucose
- Noninvasive mapping of pancreatic inflammation in recent-onset type-1 diabetes patients
- Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4
- Gestational diabetes: pathogenesis and consequences to mother and offspring.
- Anti-hyperglycemic activity of selenium nanoparticles in streptozotocin-induced diabetic rats
- The role of exendin-4-conjugated superparamagnetic iron oxide nanoparticles in beta-cell-targeted MRI.
- Closed loop insulin delivery in diabetes.
- A fluorescence-based glucose biosensor using concanavalin A and dextran encapsulated in a poly(ethylene glycol) hydrogel.
- Recent Advancement of Chitosan-Based Nanoparticles for Oral Controlled Delivery of Insulin and Other Therapeutic Agents
- Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
- Biosensors based on carbon nanotubes
- Managing diabetes with nanomedicine: challenges and opportunities
- Noninvasive imaging of pancreatic inflammation and its reversal in type 1 diabetes.
- The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo.
- Oral delivery of an anti-diabetic peptide drug via conjugation and complexation with low molecular weight chitosan.
- Fluorescence-based glucose sensors.
- Surface engineering of inorganic nanoparticles for imaging and therapy.
- Progress in Boronic Acid-Based Fluorescent Glucose Sensors
- Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo.
Cited by
- Identification of Biotechnology Urgency in the Environmental Knowledge Course
- Exploring Nano Biotechnology for detecting specific disease in Medical diagnosis and Therapeutic
- Nanotechnology for Diabetes Management: Transforming Anti-diabetic Drug Delivery Systems
- Nano bio-robots: a new frontier in targeted therapeutic delivery
- Nanoparticle mediated diagnosis of clinical biomarkers of different diseases: a medical application of nanotechnology
Related papers
- 010–Automated Insulin Delivery (Artificial Pancreas) on the Horizon: Educational Considerations for Youth with Type 1 Diabetes
- Modern strategies for management of glycaemia in type 1 diabetes
- Use of Continuous Glucose Monitoring in Pump Therapy Sensor Augmented Pump or Automated Insulin Delivery in Different Age Groups (0.5 to <26 Years) With Type 1 Diabetes From 2018 to 2021: Analysis of the German/Austrian/Swiss/Luxemburg Diabetes Prospective Follow-up Database Registry
- Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes
- New-generation diabetes management: glucose sensor-augmented insulin pump therapy
- Will the First Approved Automated Insulin Delivery System Be a Game-Changer in Type 1 Diabetes Management?
- Advances in technology for management of type 1 diabetes.
- Diabetes Management in the 80s: The Role of Home Blood Glucose Monitoring and New Insulin Delivery Systems